Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G. Hamilton, Susan M. Domchek, Magan Trottier et al.|Genetics in Medicine|2021Cited by 73
Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline <i>BRCA</i> or <i>PALB2</i> MutationsKim A. Reiss, Susan M. Domchek, Shun Yu et al.|JCO Precision Oncology|2018Cited by 61
Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline <i>BRCA</i> or <i>PALB2</i> MutationShun Yu, Kim A. Reiss, Susan M. Domchek et al.|JCO Precision Oncology|2019Cited by 37